Media Releases
Gene discovery suggests new treatment approach for liver cancer
06/04/2021
In a comprehensive analysis of human gene activation data, researchers from the Centenary Institute have discovered that the dipeptidyl peptidase-4 (DPP4) gene family is strongly implicated in the development of human hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
Dual drug approach to treat deadly melanoma
30/03/2021
Research from the Centenary Institute has found that a new dual drug approach could offer up a highly effective treatment strategy for melanoma, the most serious form of skin cancer responsible for more than 1,700 deaths each year in Australia.
Multiple sclerosis drug research funded
01/02/2021
Associate Professor Anthony Don, Head of the Lipid Metabolism and Neurochemistry Laboratory at the Centenary Institute has received a funding grant of $115,000 from MS Research Australia to help investigate and develop drugs that can better treat multiple sclerosis (MS).
Prestigious grants success for Centenary Institute researchers
16/12/2020
World-leading research into sudden cardiac death (SCD) in young people and multiple sclerosis has been boosted with two Centenary Institute researchers successfully securing prestigious NHMRC Ideas Grants.
Gut microbiome link to deadly lung disease
19/11/2020
Research led by the Centenary Institute, the University of Technology Sydney and the University of Queensland has shown for the first time a link between chronic obstructive pulmonary disease (COPD), an often fatal lung condition, and the gut microbiome.
How the humble sea sponge helped scientists unravel a 700 million-year-old mystery of evolution
06/11/2020
Australian scientists, including from the Centenary Institute, have found that humans, and most likely the entire animal kingdom, share important genetic mechanisms with a jelly-like sea sponge.
New understanding of how proteins operate
05/11/2020
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.
Anti-inflammatory benefits from gut bacteria found in fish and humans
19/10/2020
Researchers at the Centenary Institute have found that sensitivity of the immune system to ‘good’ gut bacteria is present in zebrafish, proving that the ability of an animal to benefit from good gut bugs is evolutionarily conserved whether you walk or swim.
Concealed cardiomyopathies revealed in cardiac arrest survivors
29/09/2020
Centenary Institute researchers have discovered that genetic testing can identify ‘concealed cardiomyopathies’ in nearly a quarter of sudden cardiac arrest (SCA) survivors who seem to have a normal heart.
Enzyme insight could lead to new diabetes treatment
14/09/2020
Research led by the Centenary Institute has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 (SphK2) results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.